CHFS vs. MOVE, TIVC, NDRA, NUWE, CUTR, HSDT, VRAYQ, VIVE, MDT, and MASI
Should you be buying Nuwellis stock or one of its competitors? The main competitors of Nuwellis include Movano (MOVE), Tivic Health Systems (TIVC), ENDRA Life Sciences (NDRA), Nuwellis (NUWE), Cutera (CUTR), Helius Medical Technologies (HSDT), ViewRay (VRAYQ), Viveve Medical (VIVE), Medtronic (MDT), and Masimo (MASI).
Nuwellis vs. Its Competitors
Nuwellis (NASDAQ:CHFS) and Movano (NASDAQ:MOVE) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, community ranking, media sentiment, institutional ownership, dividends, valuation and risk.
Nuwellis has a beta of 1.55, meaning that its stock price is 55% more volatile than the S&P 500. Comparatively, Movano has a beta of 0.78, meaning that its stock price is 22% less volatile than the S&P 500.
65.1% of Nuwellis shares are owned by institutional investors. Comparatively, 16.6% of Movano shares are owned by institutional investors. 0.6% of Nuwellis shares are owned by insiders. Comparatively, 13.4% of Movano shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Nuwellis received 139 more outperform votes than Movano when rated by MarketBeat users. However, 70.88% of users gave Movano an outperform vote while only 69.53% of users gave Nuwellis an outperform vote.
Nuwellis has higher revenue and earnings than Movano. Movano is trading at a lower price-to-earnings ratio than Nuwellis, indicating that it is currently the more affordable of the two stocks.
Movano has a consensus price target of $30.00, suggesting a potential upside of 4,387.66%. Given Movano's stronger consensus rating and higher possible upside, analysts clearly believe Movano is more favorable than Nuwellis.
Movano has a net margin of 0.00% compared to Nuwellis' net margin of -254.26%. Nuwellis' return on equity of -173.61% beat Movano's return on equity.
In the previous week, Movano had 134 more articles in the media than Nuwellis. MarketBeat recorded 134 mentions for Movano and 0 mentions for Nuwellis. Movano's average media sentiment score of 0.61 beat Nuwellis' score of 0.00 indicating that Movano is being referred to more favorably in the news media.
Summary
Movano beats Nuwellis on 10 of the 18 factors compared between the two stocks.
Get Nuwellis News Delivered to You Automatically
Sign up to receive the latest news and ratings for CHFS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding CHFS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Nuwellis Competitors List
Related Companies and Tools
This page (NASDAQ:CHFS) was last updated on 6/22/2025 by MarketBeat.com Staff
Buy CHFS Stock Free CHFS Stock Alerts